Amyris, Inc. Securities Litigation (2019)

If you purchased a significant amount of shares of Amyris, Inc. (NASDAQ: AMRS), you have certain options. Investors should register for updates.


Lawsuit Overview

Defendant:Amyris, Inc.
Date Filed:April 3rd, 2019
Sector:Basic Industries
Industry:Major Chemicals

According to the Complaint, Amyris purports to be an industrial biotechnology company that manufactures and
sells natural, sustainably-sourced products in health and wellness, clean beauty, and flavor and fragrance markets.

The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, the Complaint alleges that Defendants made false and/or misleading statements and/or failed to disclose: (1) that the Company lacked sufficient resources to accurately account for certain transactions; (2) that, as a result, there was a material weakness in the Company's internal controls over financial reporting; (3) that, as a result, the Company would be unable to timely file its annual report; and (4) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Sign up for free to create a personalized portfolio with tracking and e-mail alerts for Amyris, Inc.

First Identified Complaint

Shane Mulderrig, et al. v. Amyris, Inc., et al.

Date Filed:April 3rd, 2019
Class Period Start:March 15th, 2018
Class Period End:March 19th, 2019
First Identified Complaint Filings
#Document TitleFiling Date